Market Research Logo

Lucigen Corp - Product Pipeline Analysis, 2017 Update

Summary

Lucigen Corp (Lucigen) is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s product portfolio includes competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vectors, and protein expression. It also offers CloneSmart, BigEasy Linear, DNATerminator End Repair Kit, CloneDirect Rapid Ligation Kit, UltraClone DNA Ligation and Transformation Kits, Gel-Ready DNA Ladders, NxGen Exonuclease I, NxGen Lambda Exonuclease, NxGen Exonuclease III, NxGen RNAse Inhibitor, RNase I, T4 Polynucleotide Kinase and Pyrophosphatase, among others. The company offers next gen sequencing services such as DNA-specific sequencing services and RNA-specific sequencing services. Lucigen is headquartered in Middleton, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Lucigen Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Lucigen Corp Company Overview
Lucigen Corp Company Snapshot
Lucigen Corp Pipeline Products and Ongoing Clinical Trials Overview
Lucigen Corp – Pipeline Analysis Overview
Lucigen Corp - Key Facts
Lucigen Corp - Major Products and Services
Lucigen Corp Pipeline Products by Development Stage
Lucigen Corp Pipeline Products Overview
ClariLight C. difficile
ClariLight C. difficile Product Overview
ClariLight C.difficile - CLIA Waiver
ClariLight C.difficile - CLIA Waiver Product Overview
ClariLight Influenza A and B
ClariLight Influenza A and B Product Overview
Diagnostic Assay - Ebola Virus (EBoV) test
Diagnostic Assay - Ebola Virus (EBoV) test Product Overview
Diagnostic Assay - Lassa virus
Diagnostic Assay - Lassa virus Product Overview
Diagnostic Assay - Marburg Virus
Diagnostic Assay - Marburg Virus Product Overview
Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B
Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B Product Overview
Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF)
Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) Product Overview
Diagnostic Test - Staphylococcus aureus
Diagnostic Test - Staphylococcus aureus Product Overview
Diagnostic Test - West Nile Virus (WNV)
Diagnostic Test - West Nile Virus (WNV) Product Overview
Point-Of-Care Device - Arboviruses
Point-Of-Care Device - Arboviruses Product Overview
Point-Of-Care Device - HPV
Point-Of-Care Device - HPV Product Overview
Lucigen Corp - Key Competitors
Lucigen Corp - Key Employees
Lucigen Corp - Locations And Subsidiaries
Head Office
Recent Developments
Lucigen Corp, Recent Developments
May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement
Oct 29, 2014: Lucigen Announces Ralph Kauten as CEO
May 23, 2012: Lucigen Corporation Receives $2.8m SBIR Grant From NIH For Lucigen Influenza A, B & RSV test
Apr 16, 2012: Lucigen Relocates To New Facility
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Lucigen Corp Pipeline Products and Ongoing Clinical Trials Overview
Lucigen Corp Pipeline Products by Equipment Type
Lucigen Corp Pipeline Products by Indication
Lucigen Corp, Key Facts
Lucigen Corp, Major Products and Services
Lucigen Corp Number of Pipeline Products by Development Stage
Lucigen Corp Pipeline Products Summary by Development Stage
ClariLight C. difficile - Product Status
ClariLight C. difficile - Product Description
ClariLight C.difficile - CLIA Waiver - Product Status
ClariLight C.difficile - CLIA Waiver - Product Description
ClariLight Influenza A and B - Product Status
ClariLight Influenza A and B - Product Description
Diagnostic Assay - Ebola Virus (EBoV) test - Product Status
Diagnostic Assay - Ebola Virus (EBoV) test - Product Description
Diagnostic Assay - Lassa virus - Product Status
Diagnostic Assay - Lassa virus - Product Description
Diagnostic Assay - Marburg Virus - Product Status
Diagnostic Assay - Marburg Virus - Product Description
Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B - Product Status
Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B - Product Description
Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) - Product Status
Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) - Product Description
Diagnostic Test - Staphylococcus aureus - Product Status
Diagnostic Test - Staphylococcus aureus - Product Description
Diagnostic Test - West Nile Virus (WNV) - Product Status
Diagnostic Test - West Nile Virus (WNV) - Product Description
Point-Of-Care Device - Arboviruses - Product Status
Point-Of-Care Device - Arboviruses - Product Description
Point-Of-Care Device - HPV - Product Status
Point-Of-Care Device - HPV - Product Description
Lucigen Corp, Key Employees
Glossary
List of Figures
Lucigen Corp Pipeline Products by Equipment Type
Lucigen Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report